Cancer Science & Therapy

Most cancers aren’t a single sickness but a set of illnesses. it is complicated and does not easily give up its secrets. Regardless of the demanding situations cancer poses, scientists and clinicians hold to hone the way wherein they diagnose and deal with it. Modern medication means that diagnosis prices for plenty cancers are up, as are survival charges. However, with an expected 19.3 million depended on source new instances of most cancers worldwide in 2020, there may be nonetheless a whole lot work to be achieved. Chance factors for cancers Tobacco use, alcohol use, dangerous diet, physical inactivity and air pollution are chance factors for cancer (and different noncommunicable sicknesses). Among 30 and 50% of cancers can presently be prevented by using averting threat elements and enforcing current proof-primarily based prevention strategies. The cancer burden can also be decreased thru early detection of most cancers and suitable treatment and care of patients who expand most cancers.

Submission Process

• Special issue articles can include both original unpublished research articles and review articles related to the specific theme.
• Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee [selected by the guest editor(s)].
• All the articles in special issues should strictly adhere to journal style and formatting.
• Each special issue can be created with 10-15 articles.
• All accepted manuscripts can be submitted online via www.scholarscentral.org/submissions/cancer-science-therapy.html. Submission should be accompanied by a cover letter with reference to the concerned special issue theme.
• Accepted manuscripts submitted before the deadline will be published within the given timeframe for the respective journal publication.

 Once accepted and published, all special issues will be released under an open access system through HILARIS SRL and will be freely available for reading, downloading, and printing.

Cancer Science 2020 held during May 25-26, 2020 at Rome, Italy with the theme- “Strengthening the future to fight against cancer”, which was a great success. Eminent keynote speakers from various reputed institutions and organizations addressed the gathering with their resplendent presence. We extend our grateful thanks to all the momentous speakers, conference attendees who contributed towards the successful run of the conference. Cancer Science 2020 explored the new ideas and concepts on prevention, diagnosis, and treatment of the Organ-related Cancers and its innovative techniques with an interdisciplinary stage to experts, professionals to display and discuss the latest developments in the fields of clinical oncology and molecular diagnostic techniques. Cancer Science Organizing Committee extends its gratitude and congratulates the Honorable Moderators of the conference. This meeting discussion on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on Prevention, Diagnosis, and Treatment of the Organ-related Cancers and its innovative techniques.  It is crucial for oncologists to keep updated of the novel advancements in oncology and the management of cancer. It enhances cancer research with the goal of increasing cure rates

Journal of Cancer Science & Therapy is pleased to announce Special issue on the topic “Cancer history: A severe risk factor in Covid-19 patients”.

With the available global data on spread of corona virus and mortality rate in Covid-19 patients, there has been an increased risk in expression of the symptoms and mortality in patients with cancer history or patients undergoing cancer treatment. The incidence of COVID-19 in patients with cancer would be more informative in assessing whether or not patients with cancer have an increased risk of COVID-19. Additionally, there are reports that patients with cancer were prone to severe events (admission to the intensive care unit requiring invasive ventilation, or death) from COVID-19. Evidence indicates that overwhelming inflammation and cytokine-associated lung injury could be important in instigating these severe events in patients with COVID-19.

In the process of making more information available about this topic on an open access platform, Journal of Cancer Science & Therapy would like to invite all the Researchers/Doctors/Medical Professionals/Institutions to submit Case-report,  research, review, short commentary, opinion, perspective or any kind of article related to the topic and it will be processed within the next 15 days and published in our May month special issue.

Submission Process 

• Special issue articles can include both original unpublished research articles and review articles related to the specific theme
• Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
• All the articles in special issues should strictly adhere to journal style and formatting.
• Each special issue can be created with 5-7 articles.
• All accepted manuscripts can be submitted online https://www.scholarscentral.org/submissions/cancer-science-therapy.html or send as an e-mail attachment to the Editorial Office at cancerscience@medicineinsights.com 
• Submission should be accompanied by a cover letter with reference to the concerned special issue theme.

Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.hilarispublisher.com/cancer-science-therapy/instructionsforauthors.html